Parallax Volatility Advisers’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-13,551
| Closed | -$1.22M | – | 1886 |
|
|
2025
Q4 | $1.22M | Buy |
13,551
+4,834
| +55% | +$458K | ﹤0.01% | 1061 |
|
|
2025
Q3 | $859K | Sell |
8,717
-1,975
| -18% | -$196K | ﹤0.01% | 1146 |
|
|
2025
Q2 | $975K | Buy |
10,692
+6,494
| +155% | +$628K | ﹤0.01% | 1066 |
|
|
2025
Q1 | $475K | Sell |
4,198
-22,450
| -84% | -$2.4M | ﹤0.01% | 1200 |
|
|
2024
Q4 | $2.81M | Buy |
+26,648
| New | +$2.86M | 0.01% | 1034 |
|
|
2024
Q1 | – | Sell |
-725
| Closed | -$88.2K | – | 2452 |
|
|
2023
Q4 | $88.2K | Sell |
725
-2,827
| -80% | -$315K | ﹤0.01% | 1881 |
|
|
2023
Q3 | $399K | Sell |
3,552
-9,230
| -72% | -$1.17M | ﹤0.01% | 1662 |
|
|
2023
Q2 | $1.86M | Buy |
+12,782
| New | +$1.74M | ﹤0.01% | 1166 |
|
|
2022
Q4 | – | Sell |
-2,742
| Closed | -$287K | – | 3327 |
|
|
2022
Q3 | $287K | Buy |
2,742
+2,028
| +284% | +$223K | ﹤0.01% | 2196 |
|
|
2022
Q2 | $75K | Buy |
714
+178
| +33% | +$21.1K | ﹤0.01% | 2404 |
|
|
2022
Q1 | $69K | Sell |
536
-1,219
| -69% | -$147K | ﹤0.01% | 2427 |
|
|
2021
Q4 | $216K | Sell |
1,755
-2,074
| -54% | -$271K | ﹤0.01% | 1631 |
|
|
2021
Q3 | $544K | Buy |
3,829
+2,041
| +114% | +$300K | ﹤0.01% | 1491 |
|
|
2021
Q2 | $279K | Buy |
1,788
+1,764
| +7,350% | +$286K | ﹤0.01% | 1252 |
|
|
2021
Q1 | $4K | Sell |
24
-9,698
| -100% | -$1.5M | ﹤0.01% | 1245 |
|
|
2020
Q4 | $1.45M | Buy |
9,722
+6,535
| +205% | +$923K | ﹤0.01% | 1342 |
|
|
2020
Q3 | $421K | Sell |
3,187
-18,879
| -86% | -$2.47M | ﹤0.01% | 2305 |
|
|
2020
Q2 | $2.56M | Buy |
22,066
+1,109
| +5% | +$128K | ﹤0.01% | 1374 |
|
|
2020
Q1 | $2.06M | Buy |
+20,957
| New | +$2.75M | ﹤0.01% | 1213 |
|
|
2019
Q2 | – | Sell |
-24,567
| Closed | -$3.05M | – | 3919 |
|
|
2019
Q1 | $3.05M | Sell |
24,567
-760
| -3% | -$86.4K | ﹤0.01% | 848 |
|
|
2018
Q4 | $2.55M | Buy |
25,327
+4,417
| +21% | +$497K | ﹤0.01% | 962 |
|
|
2018
Q3 | $2.67M | Buy |
+20,910
| New | +$2.49M | ﹤0.01% | 937 |
|
|
2018
Q1 | – | Sell |
-4,862
| Closed | -$570K | – | 4481 |
|
|
2017
Q4 | $570K | Buy |
+4,862
| New | +$550K | ﹤0.01% | 1457 |
|
|
2017
Q3 | – | Sell |
-17,559
| Closed | -$2.03M | – | 3479 |
|
|
2017
Q2 | $2.19M | Buy |
+17,559
| New | +$2.08M | ﹤0.01% | 809 |
|
|
2017
Q1 | – | Sell |
-2,896
| Closed | -$290K | – | 4828 |
|
|
2016
Q4 | $290K | Buy |
+2,896
| New | +$310K | ﹤0.01% | 1739 |
|
|
2016
Q1 | – | Sell |
-6,486
| Closed | -$646K | – | 3883 |
|
|
2015
Q4 | $646K | Sell |
6,486
-11,465
| -64% | -$1.12M | ﹤0.01% | 1432 |
|
|
2015
Q3 | $1.64M | Buy |
17,951
+16,994
| +1,776% | +$1.7M | ﹤0.01% | 1104 |
|
|
2015
Q2 | $101K | Sell |
957
-7,713
| -89% | -$853K | ﹤0.01% | 2273 |
|
|
2015
Q1 | $989K | Buy |
8,670
+6,322
| +269% | +$721K | ﹤0.01% | 1268 |
|
|
2014
Q4 | $259K | Sell |
2,348
-6,583
| -74% | -$694K | ﹤0.01% | 2624 |
|
|
2014
Q3 | $872K | Buy |
+8,931
| New | +$878K | ﹤0.01% | 1539 |
|
Other funds holding ZBH
Parallax Volatility Advisers's ZBH Position: Q1 2026 in Review
Parallax Volatility Advisers sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 13,551 shares — an estimated $1.22M sold.
Parallax Volatility Advisers first reported a position in ZBH in Q3 2014 and held it in 31 quarters. The position peaked at $3.05M in Q1 2019. 916 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Parallax Volatility Advisers reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
- Parallax Volatility Advisers sold 13,551 Zimmer Biomet shares in Q1 2026, an estimated $1.22M.
- Parallax Volatility Advisers first reported a position in Zimmer Biomet in Q3 2014 and held it in 31 quarters.
- Parallax Volatility Advisers's Zimmer Biomet position peaked at $3.05M in Q1 2019.
- 916 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.